» Articles » PMID: 12610126

Measles Virus Infects and Suppresses Proliferation of T Lymphocytes from Transgenic Mice Bearing Human Signaling Lymphocytic Activation Molecule

Overview
Journal J Virol
Date 2003 Mar 1
PMID 12610126
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Humans are the only natural reservoir of measles virus (MV), one of the most contagious viruses known. MV infection and the profound immunosuppression it causes are currently responsible for nearly one million deaths annually. Human signaling lymphocytic activation molecule (hSLAM) was identified as a receptor for wild-type MV as well as for MV strains prepared as vaccines. To better evaluate the role of hSLAM in MV pathogenesis and MV-induced immunosuppression, we created transgenic (tg) mice that expressed the hSLAM molecule under the control of the lck proximal promoter. hSLAM was expressed on CD4(+) and CD8(+) T cells in the blood and spleen and also on CD4(+), CD8(+), CD4(+) CD8(+), and CD4(-) CD8(-) thymocytes. Wild-type MV, after limited passage on B95-8 marmoset B cells, and the Edmonston laboratory strain of MV infected hSLAM-expressing cells. There was a direct correlation between the amount of hSLAM expressed on the cells' surface and the degree of viral infection. Additionally, MV infection induced downregulation of receptor hSLAM and inhibited cell division and proliferation of hSLAM(+) but not hSLAM(-) T cells. Therefore, these tg mice provide the opportunity for analyzing and comparing MV-T cell interactions and MV pathogenesis in cells expressing only the hSLAM MV receptor with those of tg mice whose T cells selectively express another MV receptor, CD46.

Citing Articles

Human SLAM-adapted canine distemper virus can enter human peripheral blood mononuclear cells and replicate in mice expressing human SLAM and defective for STAT1 expression.

Zhai B, Ran W, Sun Y, Alcos A, Liu M, Chen J Virulence. 2025; 16(1):2457967.

PMID: 39981650 PMC: 11849921. DOI: 10.1080/21505594.2025.2457967.


Emerging Nano-/Biotechnology Drives Oncolytic Virus-Activated and Combined Cancer Immunotherapy.

Fang C, Xiao G, Wang T, Song L, Peng B, Xu B Research (Wash D C). 2023; 6:0108.

PMID: 37040283 PMC: 10079287. DOI: 10.34133/research.0108.


The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.

Maxwell R, Luksik A, Garzon-Muvdi T, Lim M Curr Neurol Neurosci Rep. 2017; 17(6):50.

PMID: 28488122 DOI: 10.1007/s11910-017-0754-x.


The Host Cell Receptors for Measles Virus and Their Interaction with the Viral Hemagglutinin (H) Protein.

Lin L, Richardson C Viruses. 2016; 8(9).

PMID: 27657109 PMC: 5035964. DOI: 10.3390/v8090250.


Measles virus hemagglutinin triggers intracellular signaling in CD150-expressing dendritic cells and inhibits immune response.

Romanets-Korbut O, Kovalevska L, Seya T, Sidorenko S, Horvat B Cell Mol Immunol. 2015; 13(6):828-838.

PMID: 26073466 PMC: 5101440. DOI: 10.1038/cmi.2015.55.


References
1.
Weidmann A, Maisner A, Garten W, Seufert M, Ter Meulen V, Schneider-Schaulies S . Proteolytic cleavage of the fusion protein but not membrane fusion is required for measles virus-induced immunosuppression in vitro. J Virol. 2000; 74(4):1985-93. PMC: 111676. DOI: 10.1128/jvi.74.4.1985-1993.2000. View

2.
Servet-Delprat C, Rivailler P, Rissoan M, Liu Y, Rabourdin-Combe C . Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med. 1997; 186(6):813-23. PMC: 2199042. DOI: 10.1084/jem.186.6.813. View

3.
Manchester M, Eto D, Valsamakis A, Liton P, Fernandez-Munoz R, Rota P . Clinical isolates of measles virus use CD46 as a cellular receptor. J Virol. 2001; 74(9):3967-74. PMC: 111910. DOI: 10.1128/jvi.74.9.3967-3974.2000. View

4.
Niewiesk S, Gotzelmann M, Ter Meulen V . Selective in vivo suppression of T lymphocyte responses in experimental measles virus infection. Proc Natl Acad Sci U S A. 2000; 97(8):4251-5. PMC: 18218. DOI: 10.1073/pnas.060012097. View

5.
Tatsuo H, Ono N, Tanaka K, Yanagi Y . SLAM (CDw150) is a cellular receptor for measles virus. Nature. 2000; 406(6798):893-7. DOI: 10.1038/35022579. View